Differential effects of taurine treatment and taurine deficiency on the outcome of renal ischemia reperfusion injury

Journal of Biomedical Science

Volumn 17, Issue SUPPL. 1, 2010, Pages

  Mozaffari, Mahmood S ^a   Abdelsayed, Rafik ^a   Patel, Champa ^a   Wimborne, Hereward ^a   Liu, Jun Yao ^a   Schaffer, Stephen W ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 2; SODIUM; TAURINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY PROXIMAL TUBULE; KIDNEY STRUCTURE; KIDNEY TUBULE NECROSIS; MALE; NONHUMAN; NUTRITIONAL DEFICIENCY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SHAM PROCEDURE; SODIUM URINE LEVEL; TAURINE DEFICIENCY; URINARY EXCRETION; URINE OSMOLALITY; VITAMIN SUPPLEMENTATION; ANIMAL; ARTICLE; DRUG EFFECT; KIDNEY; KIDNEY DISEASE; KIDNEY FUNCTION TEST; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

RATTUS;

ANIMALS; APOPTOSIS; AQUAPORIN 2; CELL PROLIFERATION; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TAURINE; TREATMENT OUTCOME;

EID: 77956041686     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-17-S1-S32     Document Type: Conference Paper

References (43)

1. Management of acute renal failure. AC Fry K Farrington, Postgrad Med J 2006 82 106 116 10.1136/pgmj.2005.038588 16461473
2. Recovery from acute renal failure predisposes hypertension and secondary renal disease in response to elevated sodium. KR Spurgeon-Pechman DL Donohoe DL Mattson H Lund L James DP Basile, Am J Physiol Renal Physiol 2007 293 269 F278 10.1152/ajprenal.00279.2006 17507599
3. Promising effects of ischemic preconditioning in renal transplantation. J Torras I Herrero-Fresneda N Lloberas M Riera J Ma Cruzado J Ma Griny Kidney Int 2002 61 2218 2227 10.1046/j.1523-1755.2002.00360.x 12028463
4. Delayed graft function: a frequent but still unsolved problem in renal transplantation. I Szwarc V Garrigue S Delmas S Deleuze G Chong G Mourad, Nephrol Ther 2005 1 6 325 334 16895703
5. Acute rejection after rat renal transplantation leads to downregulation of NA+ and water channels in the collecting duct. A Velic G Gabrils JR Hirsch R Schröter B Edemir S Paasche E Schlatter, Am J Transplant 2005 5 6 1276 1285 10.1111/j.1600-6143.2005.00890.x 15888031
6. New cellular and molecular immune pathways in ischemia/ reperfusion injury. P Boros JS Bromberg, Am J Transplant 2006 6 652 658 10.1111/j.1600-6143. 2005.01228.x 16539620
7. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. RW Schrier W Wang B Poole A Mitra, J Clin Invest 2004 114 5 14 15232604
8. Molecular mechanisms of recovery from acute renal failure. KD Liu, Crit Care Med 2003 31 8 572 S581 10.1097/01.CCM.0000081592.36382.BC 12907887
9. Recent advances in the pathophysiology of ischemic acute renal failure. JV Bonventre JM Weinberg, J Am Soc Nephrol 2003 14 2199 2210 10.1097/01.ASN.0000079785.13922.F6 12874476
10. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. DP Basile D Donohoe K Roethe JL Osborn, Am J Physiol Renal Physiol 2001 281 887 F899 11592947
11. Cellular and molecular derangements in acute tubular necrosis. P Devarajan, Curr Opin Pediatr 2005 17 193 199 10.1097/01.mop.0000152620.59425.eb 15800411
12. Stem cells in kidney regeneration following acute renal injury. F Lin, Pediatr Res 2006 59 74R 78R 10.1203/01.pdr.0000205156.85990.12 16549552
13. Bone marrow plasticity revisited: protection of differentiation in the kidney tubule? D Krause LG Cantley, J Clin Invest 2005 115 1705 1708 10.1172/JCI25540 16007248
14. Why is taurine cytoprotective? SW Schaffer J Azuma K Takahashi MS Mozaffari, Adv Exp Med Biol 2003 526 307 321 12908615
15. Is taurine a functional nutrient? T Bouckenooghe C Remacle B Reusens, Curr Opin Clin Nutr Metab Care 2006 9 728 733 10.1097/01.mco.0000247469.26414.55 17053427
16. Taurine inhibits apoptosis by preventing formation of the Apaf-1/caspase-9 apoptosome. T Takatani K Takahashi Y Uozumi E Shikata Y Yamamoto T Ito T Matsuda SW Schaffer J Azuma, Am J Physiol Cell Physiol 2004 287 949 953 10.1152/ajpcell.00042.2004 15253891
17. Taurine prevents the ischemia-induced apoptosis in cultured neonatal rat cardiomyocytes through Akt/caspase-9 pathway. T Takatani K Takahashi Y Uozumi T Matsuda T Ito SW Schaffer Y Fujio J Azuma, Biochem Biophys Res Commun 2004 316 484 489 10.1016/j.bbrc.2004.02.066 15020243
18. Taurine modulates arginine vasopressin-mediated regulation of renal function. MS Mozaffari D Schaffer, J Cardiovasc Pharm 2001 37 742 750 10.1097/00005344-200106000-00012
19. Effects of taurine and enalapril on kidney function in the hypertensive glucose-intolerant rat. MS Mozaffari N Miyata SW Schaffer, Am J Hypertens 2003 16 673 680 10.1016/S0895-7061(03)00915-4 12878374
20. Chronic taurine treatment ameliorates reduction in saline-induced diuresis and natriuresis. MS Mozaffari SW Schaffer, Kidney Int 2002 61 1750 1759 10.1046/j.1523-1755.2002.00317.x 11967024
21. Accelerated NaCl-induced hypertension in taurine deficient rat: Role of renal function. MS Mozaffari C Patel R Abdelsayed SW Schaffer, Kidney Int 2006 70 2 329 337 10.1038/sj.ki.5001503 16760912
22. Effects of chromium picolinate on glycemic control and kidney of the obese Zucker rat. MS Mozaffari R Abdelsayed JY Liu H Wimborne A El-Remessy A El-Marakby, Nutr Metab (Lond). 2009 6 51 10.1186/1743-7075-6-51 20003253
23. Role of vasopressin in diabetes mellitus-induced changes in medullary transport proteins involved in urine concentration in Brattleboro rats. D Kim JM Sands JD Klein, Am J Physiol Renal Physiol 2004 286 4 760 766 10.1152/ajprenal.00369.2003 14644754
24. Regulation and dysregulation of aquaporins in water balance disorders. S Nielsen TH Kwon J Frøkiaer P Agre, J Intern Med 2007 261 53 64 10.1111/j.1365-2796.2006.01760.x 17222168
25. Taurine ameliorates chronic streptozocin-induced diabetic nephropathy in rats. H Trachtman S Futterweit J Maesaka C Ma E Valderrama A Fuchs AA Tarectecan PS Rao JA Sturman TH Boles, et al. Am J Physiol 1995 269 3 Pt 2 429 38 7573492
26. Taurine and experimental kidney disease. H Trachtman JA Sturman, Adv Exp Med Biol 1994 359 149 57 7887256
27. Taurine attenuates renal disease in chronic puromycin aminonucleoside nephropathy. H Trachtman R Del Pizzo S Futterweit D Levine PS Rao E Valderrama JA Sturman, Am J Physiol 1992 262 1 Pt 2 117 23 1733287
28. Hypoglycemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits. K Winiarska K Szymanski P Gorniak M Dudziak J Bryla, Biochimie 2008 91 2 261 270 10.1016/j.biochi.2008.09.006 18957317
29. The effect of taurine on renal ischemia/reperfusion injury. G Guz E Oz N Lortlar NN Ulusu N Nurlu B Demirogullari S Omeroglus S Sert C Karasu, Amino Acids 2007 32 405 411 10.1007/s00726-006-0383-1 17006602
30. Donor preconditioning with taurine protects kidney grafts from injury after experimental transplantation. X Guan G Dei-Anane R Liang ML Gross A Nickkholgh M Kern J Ludwig M Zeier NN Büchler J Schmidt P Schemmer, J Surg Res 2008 146 1 127 134 10.1016/j.jss.2007.06.014 18061615
31. EPO and -MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney. H Gong W Wang TH Kwon J Jonassen C Li T Ring J FrökiAEr S Nielsen, Kidney Int 2004 66 683 695 10.1111/j.1523-1755. 2004.00791.x 15253723
32. Decreased abundance of major Na(+) transporters in kidneys of rats with ischemia-induced acute renal failure. TH Kwon J Frøkiaer JS Han MA Knepper S Nielsen, Am J Physiol Renal Physiol 2000 278 6 925 F939 10836980
33. Cell volume and the regulation of apoptotic cell death. F Lang E Gulbins I Szabo A Lepple-Wienhues SM Huber C Duranton KS Lang PA Lang T Wieder, J Mol Recognit 2004 17 473 480 10.1002/jmr.705 15362107
34. Ion channels in cell proliferation and apoptotic cell death. F Lang M Foller KS Lang PA Lang M Ritter E Gulbins A Vereninov SM Juber, J Membr Biol 2005 205 147 157 10.1007/s00232-005-0780-5 16362503
35. The taurine transporter: mechanisms of regulation. X Han AB Patters DP Jones I Zelikovic RW Chesney, Acta Physiol (Oxf) 2006 187 61 73 10.1111/j.1748-1716.2006.01573.x 16734743
36. The involvement of caspases in the CD95 (Fas/Apo-1) but not swelling-induced cellular taurine release from Jurkat T-lymphocytes. J Lang D Madlung C Siemen F Lang J Madlung D Siemen C Ellory A Lepple-Wienhues E Gulbins, Pflugers Arch 2000 440 93 99 10864002
37. Cellular response to hyperosmotic stresses. MB Burg JD Ferraris NI Dmitrieva, Physiol Rev 2007 87 4 1441 1474 10.1152/physrev.00056.2006 17928589
38. Taurine depletion, a novel mechanism for cardioprotection from regional ischemia. SN Allo L Bagby SW Schaffer, Am J Physiol 1997 273 4 Pt 2 1956 61 9362266
39. Contribution of the PI3-kinase/Akt survival pathway toward osmotic preconditioning. V Pastukh C Ricci V Solodushko M Mozaffari SW Schaffer, Mol Cell Biochem 2005 269 12 59 67 10.1007/s11010-005-2536-z 15786717
40. Taurine and its chloramine: modulators of immunity. GB Schuller-Levis E Park, Neurochem Res 2004 29 117 126 10.1023/B:NERE.0000010440.37629.17 14992270
41. Hypochlorous acid and taurine-N-monochloramine in periodontal disorders. A Mainnemare B Megarbane A Soueidan A Daniel IL Chapple, J Dent Res 2004 83 11 823 831 10.1177/154405910408301101 15505230
42. Protection against renal ischemia reperfusion injury by CD44 disruption. KM Rouschop JJ Roelofs N Claessen P da Costa Martins JJ Zwaginga ST Pals JJ Weening S Florquin, J Am Soc Nephrol 2005 16 2034 2043 10.1681/ASN.2005010054 15901765
43. Decreased capacity of immune cells to cause tissue injury mediates kidney ischemic preconditioning. MJ Burne-Taney M Liu WM Baldwin L Racusen H Rabb, J Immunol 2006 176 7015 7020 16709863